Last updated: November 17, 2025
Sponsor: Pfizer
Overall Status: Active - Recruiting
Phase
N/A
Condition
Hair Loss
Alopecia
Treatment
Litfulo
Clinical Study ID
NCT07152119
B7981084
Ages > 12 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patients with severe alopecia areata who have been determined to start treatment with Litfulo Capsule according to the approved indications of the medicinal product Treatment of severe alopecia areata in adults and adolescents 12 years or older Evidence of a personally signed and dated informed consent document indicating that the patient or their parent(s)/legal guardian, if applicable, have been informed of all pertinent aspects of the study
Study Design
Total Participants: 3000
Treatment Group(s): 1
Primary Treatment: Litfulo
Phase:
Study Start date:
August 27, 2025
Estimated Completion Date:
March 23, 2030
Study Description
Connect with a study center
Pfizer, Inc
Seoul 1835848,
South KoreaActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.